{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:54:26Z","timestamp":1784868866392,"version":"3.55.0"},"reference-count":28,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2023.2676","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T10:30:15Z","timestamp":1692873015000},"source":"Crossref","is-referenced-by-count":11,"title":["FIB\u20114 index and NAFLD fibrosis score are useful indicators for screening high\u2011risk groups of non\u2011viral hepatocellular carcinoma"],"prefix":"10.3892","volume":"19","author":[{"given":"Kenji","family":"Imai","sequence":"first","affiliation":[{"name":"Department of Gastroenterology\/Internal Medicine, Gifu University Graduate School of Medicine, Gifu 501\u20111194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Takai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology\/Internal Medicine, Gifu University Graduate School of Medicine, Gifu 501\u20111194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Unome","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology\/Internal Medicine, Gifu University Graduate School of Medicine, Gifu 501\u20111194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Miwa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology\/Internal Medicine, Gifu University Graduate School of Medicine, Gifu 501\u20111194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Hanai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology\/Internal Medicine, Gifu University Graduate School of Medicine, Gifu 501\u20111194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Suetsugu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology\/Internal Medicine, Gifu University Graduate School of Medicine, Gifu 501\u20111194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology\/Internal Medicine, Gifu University Graduate School of Medicine, Gifu 501\u20111194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"key20231009094532_b1-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1097\/00004836-200211002-00002","article-title":"Hepatocellular carcinoma: An epidemiologic view","volume":"35","author":"El-Serag","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"key20231009094532_b2-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis c virus infection: A systematic review","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Ann Intern Med"},{"key":"key20231009094532_b3-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: Global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"key20231009094532_b4-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","article-title":"Epidemiology of hepatocellular carcinoma: Consider the population","volume":"47 (Suppl)","author":"Mittal","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"key20231009094532_b5-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00535-018-1532-5","article-title":"A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011\u20132015 update","volume":"54","author":"Tateishi","year":"2019","journal-title":"J Gastroenterol"},{"key":"key20231009094532_b6-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1185\/03007995.2010.506375","article-title":"Population-based risk factors and resource utilization for HCC: US perspective","volume":"26","author":"Sanyal","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"key20231009094532_b7-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"key20231009094532_b8-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/hepr.13411","article-title":"Clinical practice guidelines for hepatocellular carcinoma: The Japan society of hepatology 2017 (4th JSH-HCC guidelines) 2019 update","volume":"49","author":"Kokudo","year":"2019","journal-title":"Hepatol Res"},{"key":"key20231009094532_b9-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"key20231009094532_b10-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"key20231009094532_b11-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.metabol.2014.01.011","article-title":"Obesity-associated mechanisms of hepatocarcinogenesis","volume":"63","author":"Karagozian","year":"2014","journal-title":"Metabolism"},{"key":"key20231009094532_b12-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000494844","article-title":"Newly proposed ALBI grade and ALBI-T score as tools for assessment of hepatic function and prognosis in hepatocellular carcinoma patients","volume":"8","author":"Hiraoka","year":"2019","journal-title":"Liver Cancer"},{"issue":"2","key":"key20231009094532_b13-MCO-19-4-02676","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-12-2","article-title":"Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population","volume":"12","author":"Sumida","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"key20231009094532_b14-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"key20231009094532_b15-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00535-021-01796-x","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020","volume":"51","author":"Tokushige","year":"2021","journal-title":"Hepatol Res"},{"key":"key20231009094532_b16-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"100322","key":"key20231009094532_b17-MCO-19-4-02676","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100322","article-title":"Non-alcoholic fatty liver disease: A patient guideline","volume":"3","author":"Francque","year":"2021","journal-title":"JHEP Rep"},{"key":"key20231009094532_b18-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020","volume":"56","author":"Tokushige","year":"2021","journal-title":"J Gastroenterol"},{"key":"key20231009094532_b19-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"174","DOI":"10.7326\/0003-4819-131-3-199908030-00003","article-title":"Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study group. inhibition of hepatocarcinogenesis by interferon therapy","volume":"131","author":"Yoshida","year":"1999","journal-title":"Ann Intern Med"},{"key":"key20231009094532_b20-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"517","DOI":"10.7326\/0003-4819-132-7-200004040-00002","article-title":"Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy","volume":"132","author":"Shiratori","year":"2000","journal-title":"Ann Intern Med"},{"key":"key20231009094532_b21-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"issue":"1542","key":"key20231009094532_b22-MCO-19-4-02676","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071542","article-title":"Increased visceral adipose tissue and hyperinsulinemia raise the risk for recurrence of Non-B Non-C hepatocellular carcinoma after curative treatment","volume":"13","author":"Imai","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20231009094532_b23-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"14058","DOI":"10.18632\/oncotarget.24500","article-title":"Increased visceral fat volume raises the risk for recurrence of hepatocellular carcinoma after curative treatment","volume":"9","author":"Imai","year":"2018","journal-title":"Oncotarget"},{"issue":"605","key":"key20231009094532_b24-MCO-19-4-02676","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030605","article-title":"Homeostatic model assessment of insulin resistance for predicting the recurrence of hepatocellular carcinoma after curative treatment","volume":"20","author":"Imai","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20231009094532_b25-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00432-013-1389-1","article-title":"Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: A prospective case series study using the d-ROM test","volume":"139","author":"Suzuki","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20231009094532_b26-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3164\/jcbn.10-149","article-title":"Increased levels of serum leptin are a risk factor for the recurrence of stage I\/II hepatocellular carcinoma after curative treatment","volume":"49","author":"Watanabe","year":"2011","journal-title":"J Clin Biochem Nutr"},{"key":"key20231009094532_b27-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/bimj.200410135","article-title":"Estimation of the Youden Index and its associated cutoff point","volume":"47","author":"Fluss","year":"2005","journal-title":"Biom J"},{"key":"key20231009094532_b28-MCO-19-4-02676","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.18632\/aging.102913","article-title":"APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma","volume":"12","author":"Cao","year":"2020","journal-title":"Aging (Albany NY)"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T08:25:37Z","timestamp":1696839937000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2023.2676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8,24]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2023.2676","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"article-number":"80"}}